Close Sidebar
Nordic Life Science
Now Reading
Finnish startup brings to market a new type of NAD metabolite measurement technology
Search for content, post, videos
Search for content, post, videos

Finnish startup brings to market a new type of NAD metabolite measurement technology

October 4, 2022
4210 Views
The medtech startup, NADMED, reveals the secrets of the human body at a metabolic level. The company's technology is based on an invention created in Professor Anu Wartiovaara’s team at University of Helsinki. After years of rigorous studies, NADMED presents a solution which allows more profoun
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.

Malin Otmani

Related Posts

Examin_Arm_Nevisense-melanoma
June 30, 2017

The US Food and Drug Administration has approved the Scibase Pre-Market Approval (PMA) for its product Nevisense. Nevisense is SciBase's device for the early detection of malignant melanoma. With the approval, SciBase can now market and sell Nevisense in the US.  According to the letter from theAlready a subscriber Login…

crowfund-kalla-ebuyercom
February 10, 2017

The funding model connects startup companies with investors and basic researchers with backers, reports Chris Tachibana. In 2012, the AssiStep, a handrail for people who need help with stairs, was just a clever student project. Last year, it hit the market. Norwegian University of Science and TecAlready a subscriber Login…

July 13, 2022

The Board of Directors of BioInvent International has resolved to issue 6,496,788 new shares in a directed share issue to international and Swedish institutional investors based on the authorization granted by the Annual General Meeting on April 28, 2022. "The performed directed share issue provideAlready a subscriber Login You have…

February 7, 2023

The financing was led by Finland’s Lifeline Ventures, an early-stage venture capital firm founded by serial entrepreneurs. This follows on from the first close of 10 million EUR in June 2022. This final close of 12 million EUR includes 5.9 million EUR equity from the European Innovation CouncilAlready a subscriber…